On-X LTI Launches Innovative Heart Valve Products at European Meeting in Barcelona
29 oct. 2012 08h00 HE
|
On-X Life Technologies Inc.
AUSTIN, Texas, Oct. 29, 2012 (GLOBE NEWSWIRE) -- On-X® Life Technologies, Inc. (On-X LTI) announced today that it is launching two new heart valve products, the On-X® Aortic Prosthetic Valve...
Boston Therapeutics Announces Clinical Study Safety Results With SUGARDOWN(R) at University of Sydney
24 janv. 2012 11h40 HE
|
Boston Therapeutics, Inc.
MANCHESTER, N.H., Jan. 24, 2012 (GLOBE NEWSWIRE) -- Boston Therapeutics, Inc. (BTI), a developer of diabetes therapeutics, announced today the clinical trial results in healthy volunteers performed at...
NanoInk Platform Proven to Reproducibly Detect Protein Biomarkers From Dried Blood Spot Samples
19 sept. 2011 09h00 HE
|
NanoInk
SKOKIE, IL--(Marketwire - Sep 19, 2011) - The Nano BioDiscovery Division of NanoInk, Inc.® provides a new generation of array-based instrument systems, assay kits, and contract services for...
Landmark Clinical Research With the On-X Heart Valve in a Poorly Anticoagulated South African Patient Group to be Presented at Major U.S. Heart Centers
01 sept. 2011 07h58 HE
|
On-X Life Technologies Inc.
AUSTIN, Texas, Sept. 1, 2011 (GLOBE NEWSWIRE) -- On-X® Life Technologies, Inc. (On-X LTI) announced today that Mervyn Williams, M.D., of Port Elizabeth, South Africa, will present the results of...
HemoBioTech and Its Innovative Blood Substitute HemoTech Could Benefit From House Resolution to Support Small Biotechnology Companies
25 mars 2010 08h00 HE
|
HemoBioTech
DALLAS, TX--(Marketwire - March 25, 2010) - Congressman Danny K. Davis (Il-7th) recently submitted House Resolution 1179, legislation that puts Congress on record in supporting biotechnology...
HemoBioTech Gains Congressional Recognition of Its Blood Substitute Technology
17 août 2009 08h38 HE
|
HemoBiotech
DALLAS, TX--(Marketwire - August 17, 2009) - HemoBioTech, Inc. (OTCBB: HMBT) has been working
with a coalition of small biotechnology firms to implement legislation that
will strengthen the Federal...
HemoBioTech to Present "Need for Blood Substitute to Prevent HIV Transmission" at 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention
02 juin 2009 10h00 HE
|
HemoBiotech
DALLAS, TX--(Marketwire - June 2, 2009) - Representatives from HemoBioTech, Inc. (OTCBB: HMBT) will present "Developing blood substitutes for the prevention of HIV
transmission," at the 5th...
Mediware Launches Blood Center Technologies
09 juil. 2008 12h30 HE
|
Mediware Information Systems, Inc.
LENEXA, Kan., July 9, 2008 (PRIME NEWSWIRE) -- Mediware Information Systems, Inc. (Nasdaq:MEDW), a provider of ClosedLoop(tm) clinical systems for blood and medication management, announced the launch...